References
- Vanhoenacker FM, Janssens K, Van Hul W, et al. Camurati-Engelmann disease. Review of radioclinical features. Acta Radiol 2003;44:430–4
- Cockayne EA. Case for diagnosis. Proc R Soc Med 1920;13:132–6
- Camurati M. Di un raro caso di osteite simmetrica ereditaria degli arti inferiori. Chirurg Organi Movimento 1922;6:662–5
- Engelmann G. Ein fall von ostheopathia hyperostotica (sclerotisans) multiplex infantilis. Forschritte Gebiete Röntgenstrahlen Nuklearmedizin 1929;39:1101–6
- Nishimura G, Nishimura H, Tanaka Y, et al. Camurati-Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones. Am J Med Genet 2002;107:5–11
- Janssens K, Gershoni-Baruch R, Van Hul E, et al. Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13. J Med Genet 2000;37:245–9
- Janssens K, ten Dijke P, Ralston SH, et al. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 2003;278:7718–24
- Ignotz RA, Massague J. Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA 1985;82:8530–4
- Janssens K, Vanhoenacker F, Bonduelle M, et al. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet 2006;43:1–11
- Campos-Xavier AB, Saraiva JM, Savarirayan R, et al. Phenotypic variability at the TGF-beta-1 locus in Camurati-Engelmann disease. Hum Genet 2001;109:653–8
- Bartuseviciene A, Samuilis A, Skucas J. Camurati-Engelmann disease: imaging, clinical features and differential diagnosis. Skeletal Radiol 2009;38:1037–43
- Ramanan AV, Hall MJ, Baildam EM, Mughal Z. Camurati-Engelmann disease – a case report and literature review. Rheumatology (Oxford) 2005;44:1069–72
- Carlson ML, Beatty CW, Neff BA, et al. Skull base manifestations of Camurati-Engelmann disease. Arch Otolaryngol Head Neck Surg 2010;136:566–75
- Gupta S, Cheikh IE. Camurati-Engelmann disease in conjunction with hypogonadism. Endocr Pract 2005;11:399–407
- Massague J, Cheifetz S, Endo T, Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 1986;83:8206–10
- Choy L, Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 2003;278:9609–19
- Cupp AS, Kim G, Skinner MK. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development. Biol Reprod 1999;60:1304–13
- Rosairo D, Kuyznierewicz I, Findlay J, Drummond A. Transforming growth factor-beta: its role in ovarian follicle development. Reproduction 2008;136:799–809
- Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, Genazzani AR. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 2008;24:4–11
- Meczekalski B, Podfigurna-Stopa A, Genazzani AR. Hypoestrogenism in young women and its influence on bone mass density. Gynecol Endocrinol 2010;26:652–7